Back to search
FDAFDA · Food and drugs·Recall number Z-2831-2018

S-SPOT REF 777, 777S Adhere to skin for marking and identifying moles in mammography.

Published August 22, 2018 · Recall initiated: June 13, 2018

Summary

FDA records medical device Class II recall Z-2831-2018, published August 22, 2018 and initiated June 13, 2018. Recalling firm: Beekley Corporation; Status: Terminated; Reported quantity: 3,384,024 pieces in total.; Lot: REF 777 - Lot Numbers: 02281802 05301801 04041801 04211801 03301801 05101802 05241801 02191801 03151801 03281801 04281801 02131802 REF 777S - Lot Numbers. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential for imaging artifact to mimic calcifications on patient's mammograms

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Beekley Corporation
Distributor
Worldwide Distribution: US (Nationwide) and countries of; AUSTRALIA, AUSTRIA, BAHRAIN, CANADA, GREAT BRITAIN, ISRAEL, SAUDI ARABIA, SOUTH AFRICA & UNITED ARAB EMIRATES.
Lot
REF 777 - Lot Numbers: 02281802 05301801 04041801 04211801 03301801 05101802 05241801 02191801 03151801 03281801 04281801 02131802 REF 777S - Lot Numbers
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was S-SPOT REF 777, 777S Adhere to skin for marking and identifying moles in mammography. recalled?

Yes. FDA published recall Z-2831-2018 on August 22, 2018. Reported hazard: There is a potential for imaging artifact to mimic calcifications on patient's mammograms

What should I do if I have this product?

Voluntary: Firm initiated · Letter